methylprednisolone acetate 40 MG/ML Injectable Suspension [Depo-Medrol]
- RxCUI
- 1358612
- RxNorm name
- methylprednisolone acetate 40 MG/ML Injectable Suspension [Depo-Medrol]
- Display name
- DEPO-Medrol (Injectable)
- Full name
- methylprednisolone acetate 40 MG/ML Injectable Suspension [Depo-Medrol]
- Term type
- SBD
- Status
- Active
- Strength
- 40 mg/ml
- Dose form
- Susp
- Route
- Injectable
- Updated
- 2026-07-24 06:52:14
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 122012
- Active start
- 122012
- Multiple ingredient
- NO
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| methylprednisolone acetate | 40 MG / 1 ML | methylprednisolone | methylprednisolone acetate |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Injectable Suspension | 316950 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| methylprednisolone | 6902 |
Source Vocabulary Codes#
| Code type | Value | Category |
|---|---|---|
| PRESCRIBABLE | Y | ATTRIBUTES |
| RXNAV_STR | DEPO-Medrol 40 MG/ML Injectable Suspension | NAMES |
| RxNorm Name | methylprednisolone acetate 40 MG/ML Injectable Suspension [Depo-Medrol] | NAMES |
| RxNorm Synonym | Depo-Medrol 40 MG/ML Injectable Suspension | NAMES |
| TTY | SBD | ATTRIBUTES |
| SPL_SET_ID | 823b0010-2b57-4e76-b5ac-4a8c2963438f | CODES |
| SPL_SET_ID | 9f1b7ce6-0733-47fa-8a14-a29a4d026992 | CODES |
| SPL_SET_ID | aa151d12-bd33-4d26-848f-2195172c9700 | CODES |
| RxCUI | 1358612 | CODES |
| MMSL_CODE | MTH_RXN_BD2312 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0009-0280-02 | 0009-0280 | Depo-Medrol methylprednisolone acetate | Pharmacia & Upjohn Company LLC | NDA011757 |
| 0009-0280-03 | 0009-0280 | Depo-Medrol methylprednisolone acetate | Pharmacia & Upjohn Company LLC | NDA011757 |
| 0009-0280-51 | 0009-0280 | Depo-Medrol methylprednisolone acetate | Pharmacia & Upjohn Company LLC | NDA011757 |
| 0009-0280-52 | 0009-0280 | Depo-Medrol methylprednisolone acetate | Pharmacia & Upjohn Company LLC | NDA011757 |
| 50090-0556-0 | 50090-0556 | DEPO-MEDROL methylprednisolone acetate | A-S Medication Solutions | NDA011757 |
Drugs@FDA Applications#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Depo-Medrol | METHYLPREDNISOLONE ACETATE | Pharmacia & Upjohn Company LLC | 823b0010-2b57-4e76-b5ac-4a8c2963438f | 2026-01-21 | Warnings, Adverse reactions | 0009-0280-51 0009-0280-03 0009-0280-02 0009-0280-52 0009-0280 00009028051 00009028052 00009028003 00009028002 1358612 |
| Depo-Medrol | METHYLPREDNISOLONE ACETATE | Pharmacia & Upjohn Company LLC | 9a7b3837-e038-48bf-97e9-78ad463760dc | 2026-01-21 | Warnings, Adverse reactions | 00009307303 00009307301 |
| Depo-Medrol | METHYLPREDNISOLONE ACETATE | Pharmacia & Upjohn Company LLC | bf1b104d-85cb-414d-a366-78068c82c883 | 2025-12-01 | Warnings, Adverse reactions | 00009307323 00009307322 |
| DEPO-MEDROL | METHYLPREDNISOLONE ACETATE | A-S Medication Solutions | aa151d12-bd33-4d26-848f-2195172c9700 | 2024-06-03 | Warnings, Adverse reactions | 50090-0556-0 50090-0556 50090055600 1358612 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 823b0010-2b57-4e76-b5ac-4a8c2963438f | Depo-Medrol 40 MG/ML Injectable Suspension | SY | 22 | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | 20260121 |
| 823b0010-2b57-4e76-b5ac-4a8c2963438f | methylprednisolone acetate 40 MG/ML Injectable Suspension [Depo-Medrol] | SBD | 22 | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | 20260121 |
| 823b0010-2b57-4e76-b5ac-4a8c2963438f | DEPO-Medrol 40 MG/ML Injectable Suspension | PSN | 22 | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | 20260121 |
| aa151d12-bd33-4d26-848f-2195172c9700 | methylprednisolone acetate 40 MG/ML Injectable Suspension [Depo-Medrol] | SBD | 19 | DEPO-MEDROL | 20240603 |
| aa151d12-bd33-4d26-848f-2195172c9700 | DEPO-Medrol 40 MG/ML Injectable Suspension | PSN | 19 | DEPO-MEDROL | 20240603 |
| aa151d12-bd33-4d26-848f-2195172c9700 | Depo-Medrol 40 MG/ML Injectable Suspension | SY | 19 | DEPO-MEDROL | 20240603 |
| f7d4269e-eb4c-46aa-805f-8e8662c80904 | DEPO-Medrol 40 MG/ML Injectable Suspension | PSN | 11 | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | 20210414 |
| f7d4269e-eb4c-46aa-805f-8e8662c80904 | methylprednisolone acetate 40 MG/ML Injectable Suspension [Depo-Medrol] | SBD | 11 | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | 20210414 |
| f7d4269e-eb4c-46aa-805f-8e8662c80904 | Depo-Medrol 40 MG/ML Injectable Suspension | SY | 11 | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | 20210414 |
| 9f1b7ce6-0733-47fa-8a14-a29a4d026992 | Depo-Medrol 40 MG/ML Injectable Suspension | SY | 6 | Depo-Medrol ® | 20260327 |
| 9f1b7ce6-0733-47fa-8a14-a29a4d026992 | DEPO-Medrol 40 MG/ML Injectable Suspension | PSN | 6 | Depo-Medrol ® | 20260327 |
| 9f1b7ce6-0733-47fa-8a14-a29a4d026992 | methylprednisolone acetate 40 MG/ML Injectable Suspension [Depo-Medrol] | SBD | 6 | Depo-Medrol ® | 20260327 |
| 41fa78f5-8f41-415e-80f3-7fee7091df5e | DEPO-Medrol 40 MG/ML Injectable Suspension | PSN | 1 | DEPO-MEDROL ® methylprednisolone acetate injectable suspension, USP | 20110628 |
| 41fa78f5-8f41-415e-80f3-7fee7091df5e | methylprednisolone acetate 40 MG/ML Injectable Suspension [Depo-Medrol] | SBD | 1 | DEPO-MEDROL ® methylprednisolone acetate injectable suspension, USP | 20110628 |
| 41fa78f5-8f41-415e-80f3-7fee7091df5e | Depo-Medrol 40 MG/ML Injectable Suspension | SY | 1 | DEPO-MEDROL ® methylprednisolone acetate injectable suspension, USP | 20110628 |
DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 9f1b7ce6-0733-47fa-8a14-a29a4d026992 | Depo-Medrol ® | Zoetis Inc. | 20260327 |
| 9a7b3837-e038-48bf-97e9-78ad463760dc | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A. | 20260121 |
| 823b0010-2b57-4e76-b5ac-4a8c2963438f | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | Pharmacia & Upjohn Company LLC | 20260121 |
| bf1b104d-85cb-414d-a366-78068c82c883 | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A. | 20251201 |
| 823b0010-2b57-4e76-b5ac-4a8c2963438f | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | Pharmacia & Upjohn Company LLC | 20251114 |
| bf1b104d-85cb-414d-a366-78068c82c883 | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A. | 20251008 |
| 9a7b3837-e038-48bf-97e9-78ad463760dc | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A. | 20251006 |
| bf1b104d-85cb-414d-a366-78068c82c883 | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A. | 20250828 |
| aa151d12-bd33-4d26-848f-2195172c9700 | DEPO-MEDROL | A-S Medication Solutions | 20240603 |
| 754e9384-f4d4-70cf-e053-2a91aa0a9748 | Point Of Care Kit LM-DEP-2 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Bupivacaine HCI safely and effectively. See full prescribing information for Bupivacaine HCI. Bupivacaine HCI Injectables, USP Initial U.S. Approval:2013 | NuCare Pharmaceuticals,Inc. | 20210504 |
| 72dcd99f-59e3-a11f-e053-2a91aa0a4bd3 | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | NuCare Pharmaceuticals,Inc. | 20210504 |
| f7d4269e-eb4c-46aa-805f-8e8662c80904 | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | A-S Medication Solutions | 20210414 |
| 9ba64a6c-fd63-4ae0-910b-9536e5021e00 | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | REMEDYREPACK INC. | 20180410 |
| 92cb6339-75ab-48eb-b304-19db59695883 | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | Proficient Rx LP | 20140205 |
| cb33bed8-6f99-4a00-aa3a-c74e4f0a17e7 | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | Pharmacia and Upjohn Company LLC | 20140124 |
| 9adc594b-c5f8-43af-ae24-96cb0a8ea0fe | National Council for Prescription Drug Programs | 20120724 | |
| 14e42df1-6eeb-4d70-b05c-7f475b77f64e | National Council for Prescription Drug Programs | 20120724 | |
| a87c022e-a1a3-4fc7-83b5-545b9db82031 | National Council for Prescription Drug Programs | 20120724 | |
| 73f87d3c-2cdf-451b-af46-1cdcf3694a87 | National Council for Prescription Drug Programs | 20120724 | |
| b0bc7e16-1801-42c2-a1f5-1dbaf8a8b6e5 | National Council for Prescription Drug Programs | 20120724 | |
| 5d1907a1-afcc-42e8-b241-417e305065b0 | National Council for Prescription Drug Programs | 20120724 | |
| 36d76072-beac-4b42-ba66-9f469d4d9ef9 | National Council for Prescription Drug Programs | 20120724 | |
| c7640deb-c893-461b-ad71-1f96ca6b6241 | National Council for Prescription Drug Programs | 20120724 | |
| d042f2d5-908d-4e80-9c5e-2e4fc590d833 | National Council for Prescription Drug Programs | 20120724 | |
| e8e71950-b4ff-4bb1-95c2-34961ce56314 | National Council for Prescription Drug Programs | 20120724 | |
| f2c67ef7-89c4-454b-bf7c-539fb4856011 | National Council for Prescription Drug Programs | 20120724 | |
| 292a8e6c-a5a0-4ffc-ad29-22641e1484d6 | National Council for Prescription Drug Programs | 20120724 | |
| 41fa78f5-8f41-415e-80f3-7fee7091df5e | DEPO-MEDROL ® methylprednisolone acetate injectable suspension, USP | Rebel Distributors Corp | 20110628 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | D10AA | Corticosteroids, combinations for treatment of acne | ATC1-4 | methylprednisolone | |
| ATC | D07AA | Corticosteroids, weak (group I) | ATC1-4 | methylprednisolone | |
| ATC | H02AB | Glucocorticoids | ATC1-4 | methylprednisolone | |
| FDASPL | N0000175576 | Corticosteroid | EPC | has_epc | methylprednisolone |
| FDASPL | N0000175450 | Corticosteroid Hormone Receptor Agonists | MOA | has_moa | methylprednisolone |
| MEDRT | D008775 | Methylprednisolone | CHEM | has_ingredient | methylprednisolone |
| MEDRT | D000077555 | Methylprednisolone Acetate | CHEM | has_ingredient | methylprednisolone acetate |
| MEDRT | D000309 | Adrenal Insufficiency | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D000309 | Adrenal Insufficiency | DISEASE | may_treat | methylprednisolone |
| MEDRT | D015210 | Arthritis, Gouty | DISEASE | may_prevent | methylprednisolone acetate |
| MEDRT | D015210 | Arthritis, Gouty | DISEASE | may_prevent | methylprednisolone |
| MEDRT | D001172 | Arthritis, Rheumatoid | DISEASE | may_prevent | methylprednisolone |
| MEDRT | D001172 | Arthritis, Rheumatoid | DISEASE | may_prevent | methylprednisolone acetate |
| MEDRT | D001249 | Asthma | DISEASE | may_treat | methylprednisolone |
| MEDRT | D001249 | Asthma | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D001607 | Berylliosis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D001607 | Berylliosis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D001932 | Brain Neoplasms | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D001932 | Brain Neoplasms | DISEASE | may_treat | methylprednisolone |
| MEDRT | D003093 | Colitis, Ulcerative | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D003093 | Colitis, Ulcerative | DISEASE | may_treat | methylprednisolone |
| MEDRT | D003874 | Dermatitis Herpetiformis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D003874 | Dermatitis Herpetiformis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | methylprednisolone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | methylprednisolone acetate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | methylprednisolone |
| MEDRT | D004892 | Erythema Multiforme | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D004892 | Erythema Multiforme | DISEASE | may_treat | methylprednisolone |
| MEDRT | D006086 | Graft vs Host Disease | DISEASE | may_prevent | methylprednisolone |
| MEDRT | D006086 | Graft vs Host Disease | DISEASE | may_treat | methylprednisolone |
| MEDRT | D006086 | Graft vs Host Disease | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D006086 | Graft vs Host Disease | DISEASE | may_prevent | methylprednisolone acetate |
| MEDRT | D006402 | Hematologic Diseases | DISEASE | may_treat | methylprednisolone |
| MEDRT | D006402 | Hematologic Diseases | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D006934 | Hypercalcemia | DISEASE | may_treat | methylprednisolone |
| MEDRT | D006934 | Hypercalcemia | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D007223 | Infant | DISEASE | ci_with | methylprednisolone |
| MEDRT | D007223 | Infant | DISEASE | ci_with | methylprednisolone acetate |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | methylprednisolone |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D007938 | Leukemia | DISEASE | may_treat | methylprednisolone |
| MEDRT | D007938 | Leukemia | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D008180 | Lupus Erythematosus, Systemic | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D008180 | Lupus Erythematosus, Systemic | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009103 | Multiple Sclerosis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D009103 | Multiple Sclerosis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009181 | Mycoses | DISEASE | ci_with | methylprednisolone acetate |
| MEDRT | D009181 | Mycoses | DISEASE | ci_with | methylprednisolone |
| MEDRT | D009182 | Mycosis Fungoides | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009182 | Mycosis Fungoides | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D009404 | Nephrotic Syndrome | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009404 | Nephrotic Syndrome | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D009461 | Neurologic Manifestations | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009461 | Neurologic Manifestations | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D010392 | Pemphigus | DISEASE | may_treat | methylprednisolone |
| MEDRT | D010392 | Pemphigus | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D012128 | Respiratory Distress Syndrome | DISEASE | may_treat | methylprednisolone |
| MEDRT | D012128 | Respiratory Distress Syndrome | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D012216 | Rheumatic Diseases | DISEASE | may_treat | methylprednisolone |
| MEDRT | D012216 | Rheumatic Diseases | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D012507 | Sarcoidosis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D012507 | Sarcoidosis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D012713 | Serum Sickness | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D012713 | Serum Sickness | DISEASE | may_treat | methylprednisolone |
| MEDRT | D012874 | Skin Diseases, Infectious | DISEASE | ci_with | methylprednisolone |
| MEDRT | D012874 | Skin Diseases, Infectious | DISEASE | ci_with | methylprednisolone acetate |
| MEDRT | D013167 | Spondylitis, Ankylosing | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D013167 | Spondylitis, Ankylosing | DISEASE | may_treat | methylprednisolone |
| MEDRT | D013585 | Synovitis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D013585 | Synovitis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D013966 | Thyroiditis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D013966 | Thyroiditis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D014397 | Tuberculosis, Pulmonary | DISEASE | may_treat | methylprednisolone |
| MEDRT | D014397 | Tuberculosis, Pulmonary | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D014605 | Uveitis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D014605 | Uveitis | DISEASE | may_treat | methylprednisolone |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | methylprednisolone |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | methylprednisolone acetate |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | methylprednisolone acetate |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | methylprednisolone |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | methylprednisolone |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000010253 | Decreased Capillary Permeability | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000010253 | Decreased Capillary Permeability | PE | has_pe | methylprednisolone |
| MEDRT | N0000010248 | Decreased Fibroblast Migration | PE | has_pe | methylprednisolone |
| MEDRT | N0000010248 | Decreased Fibroblast Migration | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | methylprednisolone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | methylprednisolone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000010246 | Decreased Polymorphonuclear Leukocyte Migration | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000010246 | Decreased Polymorphonuclear Leukocyte Migration | PE | has_pe | methylprednisolone |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | methylprednisolone |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | methylprednisolone |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | methylprednisolone |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | methylprednisolone |
| MEDRT | N0000009741 | Lysosomal Function Alteration | PE | has_pe | methylprednisolone |
| MEDRT | N0000009741 | Lysosomal Function Alteration | PE | has_pe | methylprednisolone acetate |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 40 MG/ML (expressed as methylprednisolone acetate) |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | PRESCRIBABLE | Y |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_VET_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| ATTRIBUTES | TTY | SBD |
| ATTRIBUTES | VET_DRUG | US |
| CODES | MMSL_CODE | MTH_RXN_BD2312 |
| CODES | NADA | NADA012204 |
| CODES | NDA | NDA011757 |
| CODES | RxCUI | 1358612 |
| CODES | SPL_SET_ID | 823b0010-2b57-4e76-b5ac-4a8c2963438f |
| CODES | SPL_SET_ID | 9f1b7ce6-0733-47fa-8a14-a29a4d026992 |
| CODES | SPL_SET_ID | aa151d12-bd33-4d26-848f-2195172c9700 |
| NAMES | Prescribable Synonym | DEPO-Medrol 40 MG/ML Injectable Suspension |
| NAMES | RXNAV_STR | DEPO-Medrol 40 MG/ML Injectable Suspension |
| NAMES | RxNorm Name | methylprednisolone acetate 40 MG/ML Injectable Suspension [Depo-Medrol] |
| NAMES | RxNorm Synonym | Depo-Medrol 40 MG/ML Injectable Suspension |
| NAMES | Tallman Synonym | DEPO-Medrol 40 MG/ML Injectable Suspension |
| NAMES | Tallman Synonym | methylPREDNISolone acetate 40 MG/ML Injectable Suspension [DEPO-Medrol] |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |